TORONTO–(BUSINESS WIRE)–In connection with its Reverse Takeover Transaction (the “Proposed Transaction”) with Phoenix Canada Oil Company Limited (TSXV: PCO) (“Phoenix”), as originally announced on May 30, 2022, ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) is pleased to announce its intention to complete a concurrent brokered private placement offering of subscription receipts for gross proceeds of C$20,000,000 or such greater amount as agreed to between the Company and the Agents, which
Source link
